Pathogenesis of osteoporosis and challenges for drug delivery

Advanced Drug Delivery Reviews

Volumn 42, Issue 3, 2000, Pages 165-173

  Mundy, Gregory R ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Anabolic; Drug delivery; Osteoporosis; Therapy

Indexed keywords

BONE; DISEASES; DRUG PRODUCTS; PHARMACODYNAMICS;

OSTEOPOROSIS;

CONTROLLED DRUG DELIVERY;

BONE DERIVED GROWTH FACTOR; BONE MORPHOGENETIC PROTEIN 2; FIBROBLAST GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA;

BONE MASS; BONE REMODELING; CANCELLOUS BONE; CORTICAL BONE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SLOW RELEASE FORMULATION;

EID: 0034739273     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(00)00060-0     Document Type: Article

References (36)

1. Mazess R.B. On aging bone loss. Clin. Orthop. 165:1982;239-252.
2. Riggs B.L., Wahner H.W., Dunn W.L., Mazess R.B., Offord K.P., Melton L.J. Differential changes in bone mineral density of the appendicular and axial skeleton with aging: Relationship to spinal osteoporosis. J. Clin. Invest. 67:1981;328-335.
3. Smith D.M., Khairi M.R.A., Johnston C.C. Jr. The loss of bone mineral with aging and its relationship to risk of fracture. J. Clin. Invest. 56:1975;311-318.
4. Riggs B.L., Wahner H.W., Melton III L.J., Richelson L.S., Judd H.L., Offord K.P. Rates of bone loss in the axial and appendicular skeletons of women: evidence of substantial vertebral bone loss prior to menopause. J. Clin. Invest. 77:1986;1487-1491.
5. Parfitt A.M., Matthews C.H.E., Villaneuva A.R., Kleerekoper M., Frame B., Rao D.S. Relationship between surface, volume, and thickness of iliac trabecular bone on aging and in osteoporosis: implications for the microanatomic and cellular mechanism of bone loss. J. Clin. Invest. 72:1983;1396-1409.
6. Kleerekoper M., Villanueva A.R., Stanciu J., Rao D.S., Parfitt A.M. The role of three-dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures. Calcif. Tissue Int. 37:1985;594-597.
7. Hattner R., Etker B.N., Frost H.M. Suggested sequential mode of control of changes in cell behavior in adult bone remodelling. Nature. 206:1965;489-490.
8. Frost H.M. Dynamics of bone remodeling. Bone Biodynamics. 1964;Little, Brown, Boston, MA.
9. Baron R., Vignery A., Horowitz M. Lymphocytes, macrophages and the regulation of bone remodeling. Peck W.A. Bone and Mineral Research. 1984;175-243 Elsevier, Amsterdam.
10. Boyce B.F., Yates A.J.P., Mundy G.R. Bolus injections of recombinant human interleukin-1 cause transient hypocalcemia in normal mice. Endocrinology. 125:1989;2780-2783.
11. Darby A.J., Meunier P.J. Mean wall thickness and formation periods of trabecular bone packets in idiopathic osteoporosis. Calcif. Tissue Int. 33:1981;199-204.
12. Smith D.M., Nance W.E., Kang K.W., Christian J.C., Johnston C.C. Genetic factors in determining bone mass. J. Clin. Invest. 52:1973;2800-2808.
13. Morrison N.A., Qi J.C., Tokita A., Kelly P.J., Crofts L., Nguyen T.V., Sambrook P.N., Eisman J.A. Prediction of bone density from vitamin D receptor alleles. Nature. 367:1994;284-287.
14. Hustmyer F.G., Peacock M., Hui S., Johnston C.C., Christian J. Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus. J. Clin. Invest. 94:1994;2130-2134.
15. Garnero P., Borel O., Sornay-Rendu E., Arlot M.E., Delmas P.D. Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: the OFELY study. J. Bone Miner. Res. 11:1996;827-834.
16. Johnston C.C., Miller J.Z., Slemenda C.W., Reister T.K., Hui S., Christian J.C., Peacock M. Calcium supplementation and increases in bone mineral density in children. New Engl. J. Med. 327:1992;82-87.
17. Heaney R.P. Why does bone mass decrease with age and menopause? Christiansen C. Proceedings of the 4th International Symposium on Osteoporosis and Consensus Development Conference, Hong Kong :1993;15. No. 41.
18. Parfitt A.M. Trabecular bone architecture in the pathogenesis and prevention of fracture. Am. J. Med. 82:(Suppl. 1):1987;68-72.
19. Parfitt A.M. Age-related structural changes in trabecular and cortical bone: cellular mechanism and biomechanical consequences. (a) Difference between rapid and slow bone loss. (b) Localized bone gain. Calcif. Tissue Int. 36:1984;S123-S128.
20. Parfitt A.M. Bone remodeling in the pathogenesis of osteoporosis. Med. Times. 109:1981;80-92.
21. Parfitt A.M., Mundy G.R., Roodman G.D., Hughes D.E., Boyce B.F. A new model for regulation of bone resorption, with particular reference to the effects of bisphosphonates. J. Bone Miner. Res. 11:1996;150-159.
22. Dunstan C.R., Garrett I.R., Adams R., Burgess W., Jaye M., Youngs T., Boyce R., Mundy G.R. Systemic fibroblast growth factor (FGF-1) prevents bone loss, increases new bone formation, and restores trabecular microarchitecture in ovariectomized rats. J. Bone Miner. Res. 10:(Suppl.):1995;P279.
23. Reid I.R., Chin K., Evans M.C., Jones J.G. Relation between increase in length of hip axis in older women between 1950s and 1990s and increase in age specific rates of hip fracture. Br. Med. J. 309:1994;508-509.
24. Faulkner K.G., Cummings S.R., Black D., Palermo L., Gluer C.C., Genant H.K. Simple measurement of femoral geometry predicts hip fracture: the study of osteoporotic fractures. J. Bone Miner. Res. 8:1993;1211-1217.
25. Hauschka P.V., Mavrakos A.E., Iafrati S.E., Doleman S.E., Klagsbrun M. Growth factors in bone matrix. J. Biol. Chem. 261:1986;12665-12674.
26. Mundy G.R., Boyce B., Hughes D., Wright K., Bonewald L., Dallas S., Harris S., Ghosh-Choudhury N., Chen D., Dunstan C., Izbicka E., Yoneda T. The effects of cytokines and growth factors on osteoblastic cells. Bone. 17:1995;71S-75S.
27. Yin J.J., Chirgwin J.M., Dallas M., Grubbs B.G., Massague J., Mundy G.R., Guise T.A. Blockade of TGFβ signaling inhibits parathyroid hormone-related protein (PTHrP) secretion by breast cancer cells and the development of bone metastasis. J. Clin. Invest. 103:1999;197-206.
28. Guise T.A., Mundy G.R. Cancer and bone. Endocr. Rev. 19:1998;18-54.
29. Pfeilschifter J., Chenu C., Bird A., Mundy G.R., Roodman G.D. Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro. J. Bone Miner. Res. 4:1989;113-118.
30. Cuevas P., Carceller F., Ortega S., Zazo M., Nieto I., Gimenez-Gallego G. Hypotensive activity of fibroblast growth factor. Science. 254:1991;1208-1210.
31. Burgess W.H., Shaheen A.M., Ravera M., Jaye M., Donohue P.J., Winkles J.A. Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single residue. J. Cell Biol. 111:1990;2129-2138.
32. Burgess W.H., Shaheen A.M., Hampton B., Donohue P.J., Winkles J.A. Structure-function studies of heparin-binding (acidic fibroblast) growth factor-1 using site-directed mutagenesis. J. Cell Biochem. 45:1991;131-138.
33. Burgess W.H., Friesel R., Winkles J.A. Structure-function studies of FGF-1: dissociation and partial reconstitution of certain of its biological activities. Mol. Reprod. Dev. 39:1994;56-61.
34. Mundy G., Gutierrez G., Garrett R., Harris S., Chan J., Chen D., Rossini G., Boyce B., Robbins K., McKernan P., Gaspar S., Martinez T., West R., Durnam D. Identification of a new class of powerful stimulators of new bone formation in vivo, clarification of mechanism of action, and use in animal models of osteoporosis. Bone. 23:(Suppl.):1998;1144.
35. Pak C.Y., Sakhaee K., Adams-Huet B., Piziak V., Peterson R.D., Poindexter J.R. Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Final update of a randomized controlled trial. Ann. Intern. Med. 123:1995;401-408.
36. Brown E.M., Gamba G., Riccardi D., Lombardi M., Butters R., Kifor O., Sun A., Hediger M.A., Lytton J., Hebert S.C. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature. 366:1993;575-580.